Medicina: Ematologia: Talassemie e trapianto del midollo osseo
| English |
| deferiprone (en.) |
  |
|
| Attestation |
3
|
| Part of speech |
Noun
|
| Grammatical label |
Uncountable
|
| Definition |
Deferiprone is an oral chelation agent, recently approved for use in Europe. While the results of studies on this oral agent are encouraging, complications of hepatic fibrosis may develop. Deferiprone currently is not approved for use in the United States.
|
| Definition source |
Takeshita, K. (2002). Thalassemia, Beta. E-Medicine. (INTEEN10)
|
| Context |
Iron excretion in response to deferiprone appears to depend on the iron load and rate of iron loading of patients, the dose, frequency of administration, and metabolism of the drug.
|
| Context source |
Kontoghioghes, GJ., et al. (2000). ‘Deferiprone for thalassaemia’. The Lancet 356(9227):428-9. (RISCEN184)
|
| Quasi-synonym |
Ferriprox
|
| Subject field |
Haemopoiesis
|
| Sub-field (level 1) |
Thalassemias
|
| Sub-field (level 2) |
Therapies
|
| Generic concept |
Iron-chelating agent
|
| Coordinate concept |
Desferrioxamine, HES-DFO
|
| Related concept |
Serum ferritin, iron-chelation therapy, chelation
|
| it |
Deferiprone (It.)
|
| Reliability code |
3
|
|
